These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 30243734)

  • 1. Masqueraders of central serous chorioretinopathy.
    Sahoo NK; Singh SR; Rajendran A; Shukla D; Chhablani J
    Surv Ophthalmol; 2019; 64(1):30-44. PubMed ID: 30243734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Serous Chorioretinopathy.
    Daruich A; Matet A; Behar-Cohen F
    Dev Ophthalmol; 2017; 58():27-38. PubMed ID: 28351043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy in current central serous chorioretinopathy classification.
    Singh SR; Matet A; van Dijk EHC; Daruich A; Fauser S; Yzer S; Peiretti E; Sivaprasad S; Lotery AJ; Boon CJF; Behar-Cohen F; Freund KB; Chhablani J
    Br J Ophthalmol; 2019 Jun; 103(6):737-742. PubMed ID: 30002069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of central serous chorioretinopathy: Expert panel discussion.
    Chhablani J; Anantharaman G; Behar-Cohen F; Boon C; Manayath G; Singh R
    Indian J Ophthalmol; 2018 Dec; 66(12):1700-1703. PubMed ID: 30451169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy.
    Hasanreisoglu M; Gulpinar Ikiz GD; Kucuk H; Varan O; Ozdek S
    Int Ophthalmol; 2018 Feb; 38(1):369-374. PubMed ID: 28050729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leopard-Spot Subretinal Deposits in Central Serous Chorioretinopathy.
    Marchese A; Miserocchi E; Modorati G; Querques G; Bandello F
    Retina; 2018 Jul; 38(7):e53-e54. PubMed ID: 29697592
    [No Abstract]   [Full Text] [Related]  

  • 8. Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant.
    Noh GM; Nam KY; Lee SU; Lee SJ
    Korean J Ophthalmol; 2019 Aug; 33(4):392-394. PubMed ID: 31389218
    [No Abstract]   [Full Text] [Related]  

  • 9. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
    Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
    Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicolour imaging in central serous chorioretinopathy.
    Venkatesh R; Agarwal SK; Bavaharan B; Sangai S; Jain K; Gadde SG; Prabhu V; Srinivasan P; Yadav NK
    Clin Exp Optom; 2020 May; 103(3):324-331. PubMed ID: 31489701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Therapeutic Challenges.
    La Spina C; Modorati GM; Bandello F; Querques G; Roberts P; Fawzi AA
    Retina; 2018 Feb; 38(2):432-437. PubMed ID: 28272282
    [No Abstract]   [Full Text] [Related]  

  • 12. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY.
    Matet A; Daruich A; Zola M; Behar-Cohen F
    Retina; 2018 Jul; 38(7):1403-1414. PubMed ID: 28570485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathy.
    Kahloun R; Chebbi A; Amor SB; Ksiaa I; Nacef L; Khairallah M
    Middle East Afr J Ophthalmol; 2014; 21(4):354-7. PubMed ID: 25371645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central serous chorioretinopathy mimicking as choroiditis.
    Panigrahi PK; Mahapatra MM; Minj A; Satapathy J; Samant S
    Clin Exp Optom; 2018 May; 101(3):420-421. PubMed ID: 29134698
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term results and recurrence rates after spironolactone treatment in non-resolving central serous chorio-retinopathy (CSCR).
    Herold TR; Rist K; Priglinger SG; Ulbig MW; Wolf A
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):221-229. PubMed ID: 27475933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Blanco-Garavito R; Souied EH; MacLaren RE; Querques G; Fauser S; Hoyng CB; Downes SM; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1419-1425. PubMed ID: 31123815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography.
    Azar G; Wolff B; Mauget-Faÿsse M; Rispoli M; Savastano MC; Lumbroso B
    Acta Ophthalmol; 2017 Jun; 95(4):421-427. PubMed ID: 27597633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Erectile Dysfunction in Males with Central Serous Chorioretinopathy.
    Balkarli A; Erol MK; Yalcinkaya S; Erol RS
    Semin Ophthalmol; 2018; 33(4):482-487. PubMed ID: 28328282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.
    Yasui A; Yamamoto M; Hirayama K; Shiraki K; Theisen-Kunde D; Brinkmann R; Miura Y; Kohno T
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):243-254. PubMed ID: 27497611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.